Join our Keck Graduate Institute (KGI) community as we share behind-the-scenes insights on the innovation and collaboration taking place on campus. On this podcast, we share conversations with students, faculty, staff, alumni, and other guests. Visit our website at kgi.edu and follow us on social media @KeckGrad.
#131 - Dr. Douglas Jackson
In this Industry Talk, KGI featured Douglas Jackson, who serves as the President/CEO of Project C.U.R.E.
Each week, Project C.U.R.E. delivers approximately four semi-truck loads of donated medical supplies and equipment to desperately needy people around the world. Since 1987, Project C.U.R.E. has delivered equipment and supplies to hospitals and clinics in over 135 countries. Project C.U.R.E. is consistently recognized with the highest rankings from Guidestar and Charity Navigator and was named by Forbes as one of the top 20 charities in America.
In addition to delivering nearly 200 40-foot containers each year through the C.U.R.E. Cargo program, the C.U.R.E. Clinics program sends medical professionals teams to assist partner hospitals and clinics. Project C.U.R.E. also provides hundreds of training hours through the Helping Babies Breathe and Helping Mothers Survive curriculum. Thousands of dollars of medical supplies are carried by traveling doctors and nurses in the form of C.U.R.E. Kits. More than 25,000 people volunteer with Project C.U.R.E. every year, making the organization one of the most efficient and effective grass-roots organizations in the country.
Jackson graduated magna cum laude from Northwest Nazarene University in 1982, receiving a Bachelor of Arts in Business Administration. In 1985, he earned a Juris Doctor from the University of Colorado at Boulder, receiving the American Jurisprudence Award for Excellence in the study of law. In 1992, he was awarded a PhD in Business Administration with an emphasis in finance and econometrics from the University of Colorado at Boulder, authoring a dissertation on leveraged buyouts and secondary public offerings. In 2018, Jackson was awarded the Honorary Doctorate of Medicine from ABUAD University in Ekiti, Nigeria, for his work in Africa. Jackson is a member of the Alpha Delta Sigma and the Beta Gamma Sigma national honor societies and recently completed post-graduate Executive Education at the Stanford University School of Business.
Following his admission to the bar, Jackson administered the legal affairs for the international agricultural firm of CTB, Inc., a Berkshire Hathaway company. Upon completing his PhD, Jackson opened the Fermanian Business Center at Point Loma University in San Diego, CA. As Executive Director, he developed and implemented numerous programs and seminars to advance business opportunities for college students and business professionals in the San Diego community and abroad. In 1995, Jackson assumed the role of Provost at Colorado Christian University. In this capacity, he oversaw the university’s academic, financial, operational, advancement, and student life functions.
In addition to his work at Project C.U.R.E., Jackson has taught at the university level in the disciplines of finance, investments, and leadership development, legal and international issues. He is a frequent speaker and lecturer to colleges and universities, conferences such as TEDx, as well as civic, corporate and community organizations.
Jackson is a Rotary International Paul Harris Fellow and is a past President of the Denver Rotary Club #31. His board service includes InterAction, the Partnership for Quality Medical Donations, WorldDenver, The Nanda Center for International and Comparative Law at the University of Denver, the World Trade Center Denver, and the Rueckert-Hartman College for Health Professionals at Regis University. He is a member of the National Who’s Who, Registry #57689, and a graduate of the leadership program LEAD San Diego. Jackson received the Lifetime Achievement Award in Healthcare from the American Red Cross, Innovative Philanthropy Prize from Prince Albert II, the Civis Princeps recognition from Regis University, the 5280 Magazine Philanthropist of the Year, and accepted the CoBiz “Best Places to Work” and Colorado Ethics in Business
#130 - Bonnie Anderson
This Industry Talk features Bonnie H. Anderson, the Chairman and Chief Executive Officer of Veracyte, a leading genomic diagnostics company that leverages deep genomic insights to transform care. Ms. Anderson’s career spans over 30 years in regulated diagnostics and life science markets. She cofounded Veracyte in 2008 and served as the company’s President and Chief Executive Officer until 2016, when she was also appointed Chairman of the Board.
Prior to Veracyte, Ms. Anderson provided strategic consulting services to venture capital firms and early-stage businesses following 18 years in leadership positions at Beckman Coulter. Ms. Anderson is a trustee emeritus of KGI and graduated from Indiana University of Pennsylvania with a Bachelor of Science degree in Medical Technology. Under Ms. Anderson’s leadership, Veracyte has been named a “Top Workplace” by the Bay Area News Group, based solely on employee feedback, for seven consecutive years (2014-2020).
Learn more about KGI: https://www.kgi.edu.
Learn more about Veracyte: https://www.veracyte.com.
#129 - DNA Today Rebroadcast Featuring Dr. Barbara Fortini
Dr. Barbara Fortini joins DNA Today host Kira Dineen to discuss the growing career opportunities in genomic data analytics. Fortini is the program director for KGI's Master of Science in Human Genetics and Genomic Data Analytics program. She also teaches their genetic counseling students.
Her research interests focus on colorectal cancer, the third most common cancer in the US. Genome-wide association studies have now identified dozens of common genomic variants linked to small increases in colorectal cancer risk. Her research group seeks to identify the functional variants responsible for the increased cancer risk at GWAS-identified loci and to understand the role of these variants in cancer etiology. Previous work has shown that many functional variants lie in gene enhancer elements, leading to allele-specific gene expression of both known cancer-associated genes and novel genes. By comprehensively characterizing risk loci, her team hopes to identify additional novel genes involved in colorectal cancer and better understand the role of enhancers in gene expression in healthy and cancer cells.
#128 - Understanding COVID-19 and Vaccines
We're excited to share the audio from a webinar presented by KGI Dean of Research Larry Grill on December 14, 2020.
The webinar focused on the body’s immune response when it’s infected with the coronavirus SARS-CoV-2, the different types of vaccines that fight virus diseases, and how AstraZeneca, Pfizer, and Moderna are developing their COVID-19 vaccines.
You can watch the entire webinar at http://kgi.edu/covid-webinar-replay.
#127 - Biocon Academy Webinar
As a partner with KGI, the Biocon Academy recently celebrated seven years of imparting knowledge to more than 700 students in the life sciences sector. On November 25, they hosted a special webinar featuring KGI's President Sheldon Schuster and other experts from the biotech industry.
Speakers for the session included:
Sheldon Schuster, President, KGI Jim Widergren, Broad Chair, KGI Daniel Bradbury, Trustee, KGI Steven Galson, SVP, GRA & Safety, Amgen Sue Behrens, Director, Amgen Bioprocessing Center at KGI
#126 - KGI Student Government
In this episode, we are featuring KGI student government leaders Erik Wehse, Divij Gulati, and Narine Kareptyan. Through the interview, they discuss how they became interested in science and healthcare, their KGI experience, how COVID-19 has impacted their learning, and their career aspirations.
We encourage you to connect with KGI Student Government on Instagram: @kgistudentgov.
Hear about amazing things happening at the institute as well as interesting developments in the health sciences and biotech industries.
This podcast is a fantastic cross representation of our community of both internal and external stakeholders! #innovatorsstarthere